Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: Sweden Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20111
20132
20141
20182
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Bayer1
Boston Scientific Corporation1
CSL Behring1
Gilead Sciences1
Janssen Research & Development, LLC1
Karolinska Institutet1
MedTrace Pharma A/S1
Novartis Pharmaceuticals1
University Hospital, Linkoeping1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease11
Myocardial Infarction5
Stroke4
Acute Coronary Syndrome2
Angina Pectoris2
Angina, Unstable2
Cardiovascular Diseases2
Heart Diseases2
Heart Failure2
Peripheral Arterial Disease2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.